Baidu
map

JAMA:PFC可能使儿童接种疫苗失效

2012-02-15 towersimper 生物谷

图片来自美国疾病控制中心公共健康图片库,James Gathany。 多氟化合物(polyfluorinated compounds, PFCs)是一种含氟的化学物,用于多种多样的产品中,从不沾锅厨具到纸盘和微波炉爆米花袋。接触PFCs的儿童对接种抵抗破伤风之类的传染性疾病的疫苗可能不能作出反应。根据发表在Journal of the American Medical Association


图片来自美国疾病控制中心公共健康图片库,James Gathany。

多氟化合物(polyfluorinated compounds, PFCs)是一种含氟的化学物,用于多种多样的产品中,从不沾锅厨具到纸盘和微波炉爆米花袋。接触PFCs的儿童对接种抵抗破伤风之类的传染性疾病的疫苗可能不能作出反应。根据发表在Journal of the American Medical Association期刊上的一项研究,血液中PFC水平增加与疫苗失效风险提高3倍存在关联。

美国哈佛公共卫生学院环境传染病学家Philippe Grandjean和他的同事们在丹麦测量了587名儿童身上的PFC水平,其中这些儿童可以分为仍然处于母亲子宫中、年龄5岁(他们接受加强疫苗注射时)和7岁。他们也测量了接种抵抗疾病的疫苗产生的抗体水平。在他们接受疫苗加强注射时,这些儿童中大约26%有较低的抵抗破伤风的抗体水平,而且37% 也有较低地免受白喉的能力。在出生前有最高PFC水平的儿童当他们长大时有着最低的抗体保护水平。

Grandjean猜测这种关联是PFCs伤害免疫系统的结果。美国国家环境卫生科学研究所免疫学家Dori Germole告诉《自然》期刊,“这篇论文的数据跟过去几年利用实验室动物发表的论文中的数据非常吻合。这些化合物是免疫抑制剂。”

Grandjean研究小组之前的流行病学研究也将多氯联苯(polychlorinated biphenyls, PCBs)与免疫损伤连接起来,但是PFCs似乎有着更强的抑制效果。在美国,人们已经完全停止生产一些PFCs,但是Grandjean说这些结果需要人们重新考虑一下对这些化学物制定法规的方式。他告诉《自然》期刊,“人们没有施加足够的压力阻止生产有发育毒性的PFCs成为优先选择。这确实是一个更加大的问题。”

doi:10.1001/jama.2011.2034
Serum Vaccine Antibody Concentrations in Children Exposed to Perfluorinated Compounds

Philippe Grandjean, MD, DMSc; Elisabeth Wreford Andersen, PhD; Esben Budtz-Jørgensen, PhD; Flemming Nielsen, PhD; Kåre Mølbak, MD, DMSc; Pal Weihe, MD; Carsten Heilmann, MD, DMSc

Context Perfluorinated compounds (PFCs) have emerged as important food contaminants. They cause immune suppression in a rodent model at serum concentrations similar to those occurring in the US population, but adverse health effects of PFC exposure are poorly understood.

Objective To determine whether PFC exposure is associated with antibody response to childhood vaccinations.

Design, Setting, and Participants Prospective study of a birth cohort from the National Hospital in the Faroe Islands. A total of 656 consecutive singleton births were recruited during 1997-2000, and 587 participated in follow-up through 2008.

Main Outcome Measures Serum antibody concentrations against tetanus and diphtheria toxoids at ages 5 and 7 years.

Results Similar to results of prior studies in the United States, the PFCs with the highest serum concentrations were perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA). Among PFCs in maternal pregnancy serum, PFOS showed the strongest negative correlations with antibody concentrations at age 5 years, for which a 2-fold greater concentration of exposure was associated with a difference of −39% (95% CI, −55% to −17%) in the diphtheria antibody concentration. PFCs in the child's serum at age 5 years showed uniformly negative associations with antibody levels, especially at age 7 years, except that the tetanus antibody level following PFOS exposure was not statistically significant. In a structural equation model, a 2-fold greater concentration of major PFCs in child serum was associated with a difference of −49% (95% CI, −67% to −23%) in the overall antibody concentration. A 2-fold increase in PFOS and PFOA concentrations at age 5 years was associated with odds ratios between 2.38 (95% CI, 0.89 to 6.35) and 4.20 (95% CI, 1.54 to 11.44) for falling below a clinically protective level of 0.1 IU/mL for tetanus and diphtheria antibodies at age 7 years.

Conclusion Elevated exposures to PFCs were associated with reduced humoral immune response to routine childhood immunizations in children aged 5 and 7 years.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2054785, encodeId=d0f62054e8586, content=<a href='/topic/show?id=88bc141167c' target=_blank style='color:#2F92EE;'>#PFC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14116, encryptionId=88bc141167c, topicName=PFC)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Thu Jul 05 16:57:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632324, encodeId=b2981632324f6, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Fri Jan 25 22:57:00 CST 2013, time=2013-01-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2054785, encodeId=d0f62054e8586, content=<a href='/topic/show?id=88bc141167c' target=_blank style='color:#2F92EE;'>#PFC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14116, encryptionId=88bc141167c, topicName=PFC)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLx96cCLjNYsHar1XErTVibOydfEC9iaYgrXp3SicXwntSAEDeQAlM2vLqTfm6oPORxaib3UIgyHQJJ7A/132, createdBy=36f02500138, createdName=ms6980045490879608, createdTime=Thu Jul 05 16:57:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632324, encodeId=b2981632324f6, content=<a href='/topic/show?id=6b055669ed7' target=_blank style='color:#2F92EE;'>#接种疫苗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56697, encryptionId=6b055669ed7, topicName=接种疫苗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0421898956, createdName=zz12341241, createdTime=Fri Jan 25 22:57:00 CST 2013, time=2013-01-25, status=1, ipAttribution=)]

相关资讯

Cancer Res.:发现治疗癌症的新疫苗

据12月21日医疗快线报道,爱尔兰都柏林三一学院的科学家开发出一种新的疫苗用于在临床前阶段治疗癌症。研究组由都柏林三一学院实验免疫学教授 Kingston Mills领导,他们发现了一种新的方法来治疗疾病,这种新方法基于调控机体对恶性肿瘤的免疫反应。这一发现已申请专利,并且计划开发出疫苗供癌症患者临床使用。 第一种疫苗Sipuleucel-T(Provenge)于去年通过许可用于对激素治疗无效的

西班牙艾滋病疫苗将人体试验

     显微镜下的HIV病毒   据外媒9月28日报道,西班牙科学家声称,他们研制出了预防艾滋病的疫苗,未来艾滋病的治疗或许将和治疗普通疱疹一样简单。   试验中,研究者们发现24名测试者中92%的实验者在注射了MVA-B疫苗后都对HIV病毒产生抗体。项目主管埃斯特本教授表示:“如果将来HIV病毒再度出现在人体内,淋巴系统仍旧可以识别它。”   “我们的身体内充满了淋巴系统,每一处都能抵

AIDS:新疫苗为治疗HIV感染带来希望

New HIV-vaccine tested on people. (Credit: Image courtesy of Institute of Tropical Medicine Antwerp) 近日,来自安特卫普大学和安特卫普医院的研究人员用一种治疗HIV的疫苗对第一批志愿者进行测试,研究者从志愿者体内取出白血细胞,注射入疫苗,然后输送回志愿者体内,一段时间后,志愿者体内的免疫反应表现良

FDA批准辉瑞Prevnar13肺炎球菌疫苗扩大适用范围

12月30日,FDA批准将辉瑞(Pfizer Inc., PFE)旗下Prevnar 13肺炎球菌疫苗的适用范围扩展至50岁及以上的成年人,以防止肺炎球菌疾病的蔓延,此前FDA已经批准Prevnar 13可以用于幼儿。 FDA依照其严重及威胁生命疾病治疗的审批程序,批准了最新的药物使用范围。FDA审查小组在11月份曾经表示,临床资料支持Prevnar 13肺炎球菌疫苗的使用范围扩展,这一疫苗在2

疫苗:“伏击”肿瘤的新战术

来源:中国医学论坛报   美国学者使用病毒表达正常组织细胞cDNA文库作为抗肿瘤疫苗,借助其广谱抗原覆盖,在动物试验中治愈肿瘤   由于缺乏特异性肿瘤相关抗原(TAAs)以及可以有效呈递抗原的载体,肿瘤的免疫治疗一直难以取得突破性进展。   最新出版的《自然医学》[Nat Med 2011,17(7):854]杂志刊登美国科学家的一项研究发现,使用高度免疫原性的溶瘤性

新方法推进丙肝疫苗研发

来源:医学论坛网   近日,法国学者Pierre Garrone等开发了一种基于逆转录病毒Gag制成假病毒样颗粒(VLPs)、专门诱导产生中和抗体(NAbs)的疫苗平台。他们称,这种可用大量丙型肝炎病毒(HCV)包膜糖蛋白制成假VLP的平台,代表了病毒性疫苗开发的一种新方法。该研究发表于《科学-转化医学》【Sci Transl Med 3 August 2011 3:94ra71】。   慢性

Baidu
map
Baidu
map
Baidu
map